Medifast (NYSE:MED – Get Free Report) and Dermata Therapeutics (NASDAQ:DRMA – Get Free Report) are both small-cap consumer staples companies, but which is the better business? Get Medifast alerts:Institutional & Insider Ownership95.5% of Medifast shares are owned by institutional investors. Comparatively, 8.7% of Dermata Therapeutics shares are owned by institutional investors. Net Margins Return on Equity Return on Assets Medifast -8.08% -6.69% -5.25% Dermata Therapeutics N/A -127.91% -105.05%Analyst RecommendationsThis is a breakdown of current recommendations and price targets for Medifast and Dermata Therapeutics, as provided by MarketBeat. Given Dermata Therapeutics’ higher possible upside, analysts plainly believe Dermata Therapeutics is more favorable than Medifast.